Meet us next:   BIO-EUROPE 2025 – 3-5 November  ●  ISSCR International Symposium (Boston) 2025 – 11-12 December  ●  more on our events calendar

Prostate Cancer Related Human Specimens

1468 Prostate Cancer Patients

Note: The majority of patients have donated multiple samples.

Biorepository icon: frozen samples

Frozen samples: 325

Biorepository icon: serum samples

Serum: 451

Biorepository icon: FFPE samples

FFPE: 166

Biorepository icon: DNA samples

DNA: 870

Biorepository icon: RNA samples

RNA: 17

Additional Information

  • Comprehensive, de-identified, covariate data such as age, gender, diet, body mass index (BMI), and race in addition to complete diagnostic and treatment history
  • Access to additional samples and longitudinal data are available for some custom programs.

Speak to our experts

Global Biorepository

Inventory by disease

NEW COVID-19

On the REPROCELL blog

Latest in Drug Discovery

How Human Tissue Testing Adds Commercial Value for Shareholders

How Human Tissue Testing Adds Commercial Value for Shareholders

Discover how human tissue testing enhances shareholder value, exploring its impact on drug discovery, precision medicine, and regenerative medicine within the life sciences industry.

03 September 2025

NIH Announces End to Exclusive Funding for Animal Model Research

NIH Announces End to Exclusive Funding for Animal Model Research

NIH ends exclusive funding for animal model research, promoting New Approach Methodologies like organ-on-a-chip systems and human tissue testing.

18 August 2025

Subcutaneous Artery Assays Help Us to Understand Blood Pressure Regulation

Subcutaneous Artery Assays Help Us to Understand Blood Pressure Regulation

Explore how subcutaneous artery assays enhance understanding of blood pressure regulation and aid in the development of safer, more effective cardiovascular drugs.

07 July 2025

More in Drug Discovery